Journal articleJ Clin Oncol2016
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.
- Journal
- J Clin Oncol
- Published
- 30 September 2016
- Citations
- 218
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- Builds on itRandomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer NCT01121848↗
- BackgroundThe First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients NCT05168527↗
- BackgroundTAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma NCT04923529↗